Send us a text

In this episode of the WTR Small-Cap Spotlight podcast, we are joined by Ludwig Enterprises (OTC: LUDG) Co-Founder and Chief Scientific Officer Marvin Hausman MD to talk about the company's innovative and proprietary mRNA genomic technology. Dr. Hausman discusses how it revolutionizes early detection of chronic inflammatory-driven diseases like cancer and advances the adoption of personalized medicine.

Send us a text

In this special episode of the WTR Small-Cap Spotlight Podcast, Jeff Karcher, Global Managing Director of the Texas Stock Exchange (TXSE), joins host Tim Gerdeman, Vice Chair & Co-Founder of Water Tower Research. With its highly anticipated launch planned for 2026, TXSE is positioning itself as a transformative force in U.S. capital markets. Backed by leading investors including BlackRock, Citadel, and Charles Schwab, the exchange plans to challenge incumbents like NYSE and NASDAQ by offering a fully electronic, pro-business, Dallas-based marketplace.

Jeff shares insights into TXSE’s launch timeline, listing requirements, competitive advantages, and how Texas’s rising profile in finance and technology creates a unique backdrop for this ambitious project.

Send us a text

In this episode of WTR Small Cap Spotlight, host Tim Gerdeman, Vice Chair, Co-Founder and Chief Marketing Office of Water Tower Research is joined with Alex Verge, President & CEO of Journey Energy and Managing Director in Energy, Chris Degner for a discussion on Journey’s growth investments in the in the Duvernay Shale. The conversation covers the economics of recent wells brought online, the depth of inventory for growth, underpinned with a stable, free cash flow generating production base and recent developments in the Canadian energy sector

Send us a text

In this episode of WTR Small-Cap Spotlight, host Shawn Severson, CEO and Co-Founder of Water Tower Research, is joined by Herbalife CFO John DeSimone and WTR’s Head of Consumer Products Equity Research Doug Lane for an in-depth discussion on Herbalife’s improving business trends, strategic product and technology launches, and capital allocation priorities. The conversation covers leadership changes, sales force momentum, the launch of the Pro2col App, new health supplements, and the company’s disciplined approach to debt reduction and growth investment.

Send us a text

CEO Brent Lucas of Envoy Medical (NASDAQ: COCH), an innovative hearing health technology company and sole US-domiciled cochlear implant company joins the WTR Small-Cap Spotlight podcast to talk about hearing loss, the third most chronic physical condition prevalent in the US, and how Envoy's innovative device technology can disrupt the hearing solutions market that has long lacked transformative advancements. Lucas discusses Envoy's two fully implantable hearing solution products, one in the market (Esteem), the only FDA approved middle ear implant for moderate to severe hearing loss, and the other (Acclaim), a cochlear implant targeting severe to profound hearing loss which is currently in the advanced stages of clinical development (Acclaim), the competitive landscape and the commercial opportunities.

Send us a text

The passage of the Guiding and Establishing National Innovation for U.S. Stablecoins (GENIUS) Act, signed into law on July 18, 2025, represents a landmark moment for cryptocurrency regulation in the United States. Hear from leaders in crypto like Galaxy Digital and BTCS, and miners like Greenidge, BitFuFu, and Soluna on the near term and long term impacts of the US legislation.

Send us a text

In this special Flashcast episode of the WTR Small-Cap Spotlight, host Tim Gerdeman sits down with Dr. John Roy to explore the explosive trend of companies raising significant capital specifically to invest in cryptocurrency—a hot topic recently featured in the Wall Street Journal. They dive into the staggering scale of this trend, with nearly 100 companies announcing plans to raise over $43 billion for crypto purchases since June alone. John explains how the GENIUS Act has paved the way for greater corporate crypto adoption, especially around stablecoins, and outlines potential risks, including crypto's inherent volatility. The discussion highlights key players such as Capital Group and Galaxy Digital, who are leading this bold move into the crypto space.

Tune in for expert insights into what's fueling this surge—and whether it's sustainable.

Send us a text

In this episode of our WTR Small Cap Spotlight, we sat down with LifeVantage (NASDAQ: LFVN ) CEO Steve Fife and CMO Julie Boyster to drill down on the science of nutrigenomics, which is the study of how nutrients impact our genes, and how LifeVantage’s proprietary formulations of naturally found ingredients work together to activate genes and help improve overall health and wellbeing. Recent clinical studies further demonstrate the efficacy of the company’s new patent-pending MindBody GLP-1 System, and the company discusses additional synergistic benefits from combining MindBody with the company’s flagship Nrf2 Synergizer.